These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7653332)

  • 1. The long term prophylaxis of affective disorders.
    Koukopoulos A; Reginaldi D; Minnai G; Serra G; Pani L; Johnson FN
    Adv Biochem Psychopharmacol; 1995; 49():127-47. PubMed ID: 7653332
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder.
    Waters B; Lapierre Y; Gagnon A; Cahudhry R; Tremblay A; Sarantidis D; Gray R
    Biol Psychiatry; 1982 Nov; 17(11):1323-9. PubMed ID: 6817830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels.
    Mauri MC; Laini V; Scalvini ME; Volonteri LS; Ferrari MS; Panza G
    Eur Rev Med Pharmacol Sci; 1999; 3(2):63-9. PubMed ID: 10827806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse.
    Harvey NS; Kay R
    J Clin Psychopharmacol; 1991 Dec; 11(6):362-7. PubMed ID: 1770155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long term lithium treatment of affective disorders. Long term effects and side effects].
    Hofmann G; Grünberger J; König P; Presslich O; Wolf R
    Psychiatr Clin (Basel); 1974; 7(3):129-48. PubMed ID: 4464541
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of lithium carbonate in psychiatric therapy. Apropos of 85 cases].
    Darcourt G
    Psychopharmacologie; 1973; 0(0):26-42. PubMed ID: 4599704
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of the use of lithium to prevent recurrence of affective psychosis].
    Lange E; Heisig W; Felber W; König L
    Psychiatr Neurol Med Psychol (Leipz); 1989 Aug; 41(8):476-84. PubMed ID: 2813609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lithium level and interepisode functioning in bipolar disorder.
    Goodnick PJ; Fieve RR
    Am J Psychiatry; 1985 Jun; 142(6):761-2. PubMed ID: 4003601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder.
    Frank E; Kupfer DJ; Thase ME; Mallinger AG; Swartz HA; Fagiolini AM; Grochocinski V; Houck P; Scott J; Thompson W; Monk T
    Arch Gen Psychiatry; 2005 Sep; 62(9):996-1004. PubMed ID: 16143731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of prevention of endogenous affective diseases using lithium].
    Schou M
    Nervenarzt; 1974 Aug; 45(8):397-418. PubMed ID: 4214299
    [No Abstract]   [Full Text] [Related]  

  • 12. Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder.
    Calabrese JR; Rapport DJ
    J Clin Psychiatry; 1999; 60 Suppl 5():5-13; discussion 14-5. PubMed ID: 10192402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic.
    Maj M; Pirozzi R; Magliano L; Bartoli L
    Am J Psychiatry; 1998 Jan; 155(1):30-5. PubMed ID: 9433335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium carbonate in the treatment and prophylaxis of recurrent affective disorders: long term follow-up.
    Warick LH
    Bull Los Angeles Neurol Soc; 1970 Oct; 35(4):169-80. PubMed ID: 4990519
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
    Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
    Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis.
    Chand PK; Mattoo SK; Sharan P
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):311-8. PubMed ID: 15149299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
    Oostervink F; Nolen WA; Hoenderboom AC; Kupka RW
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):401-4. PubMed ID: 10719540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prophylactic effect of lithium salt in affective psychoses with special references to patients with therapeutic failures].
    Krzyzowski J; Skaryszewska J; Marcjan K
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():235-8. PubMed ID: 829629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium prophylaxis in recurrent affective illness.
    Prien RF; Klett CJ; Caffey EM
    Am J Psychiatry; 1974 Feb; 131(2):198-203. PubMed ID: 4587809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.